| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 9.1 Billion |
| 2025 Market Size | USD 9.7 Billion |
| 2032 Forecast | USD 15.2 Billion |
| Growth Rate (CAGR) | 6.7% |
| Largest Region | Europe |
| Fastest Growing Region | APAC |
| Nature of the Market | Consolidated |
| Largest Application Category | General Imaging |
|
Explore the market potential with our data-driven report
The ultrasound devices market size stood at USD 9.1 billion in 2024, and it will witness a CAGR of 6.7% during 2025–2032, to increase to USD 15.2 billion by 2032.
High-frequency sound waves are used in ultrasound to create images of anatomical structures, which are subsequently analyzed by medical specialists to look for abnormalities. With this technology, a number of chronic diseases affecting the important body parts, including the joints, arteries in the abdomen, and the heart, can be diagnosed. Moreover, it is one of the safest non-invasive techniques for inspecting organs.
This technique is widely used for minimally invasive diagnosis, by visualizing the tissues and organs of the body. It is are also used in interventional radiology for fluid management. Some of the ultrasound-guided procedures are fluid collection by needle aspiration and tissue sampling. Since minimally invasive procedures cause less pain and do not require a long stay in a hospital, the preference for them is increasing, which, in turn, is leading to the growth of the ultrasound devices industry.
Hence, the industry is growing at a significant rate due to the booming geriatric population, rising prevalence of chronic and lifestyle-associated diseases, such as cardiovascular diseases and cancer, and increasing healthcare expenditure. The geriatric population is prone to diseases due to its low immunity, thus leading to the expanding demand for diagnosis and treatment. This would increase the demand for ultrasonograms, as they are cost-effective, especially over CTs and MRIs, and non-invasive. The prevalence of chronic diseases, such as heart disease, cancer, respiratory diseases, and diabetes, is increasing due to the alterations in lifestyles and the lack of access to preventive care. For instance, more than 18 million cancer cases are diagnosed and nearly 10 million deaths are recorded around the world every year, equaling nearly one in six deaths. The rising prevalence of such diseases would increase the demand for diagnostic and therapeutic ultrasound procedures, which are cost-effective and minimally invasive.
In addition, the advancements in the technology of ultrasonography equipment and the growing demand for minimally invasive diagnoses and therapeutics are driving the global market.
Moreover, the growing number of product launches and development of small, portable devices for point-of-care applications are the key trends being observed. The leading market players are also focused on creating cutting-edge systems that use artificial intelligence. The idea behind this step is to tackle some of the drawbacks of conventional devices, such as the lengthy examination times, occasionally poor image quality, and reliance on experts for image acquisition and interpretation.
In 2024, the general imaging category held the largest share, of 45%. This is owing to the growing availability of high-intensity focused ultrasound (HIFU) and the preference for them among physicians during tissue biopsy and the treatment of cancer and many other diseases.
The OB/GYN category will witness the fastest growth due to the increasing awareness of regular prenatal examinations. An obstetric ultrasound is routinely performed during the pregnancy for evaluating the development and health of the fetus. The ultrasound scan provides real time images of the fetus showing the movement and its heartbeat.
It is also used to measure the size of the fetus, visualize the number of fetuses in the uterus, check the sex and position of the baby, detect pathologies and analyses fetal development. As per studies, each year, 8 million babies are born with congenital defects, to detect which prenatal ultrasounds are vital. In addition, it is also used to determine the amount of amniotic fluid, and determine tumors of ovary and breast. In recent years, the developments in doppler ultrasound technology have expanded the application in the field of obstetrics.
These applications are covered:
The trolley/cart-based category dominates the market in contemporary times. These devices are mainly used in large healthcare institutions, clinics and hospitals. They have better functionality and more imaging options as compared to portable sonography machines.
The compact/handheld category will witness the higher CAGR, of 8%, during the forecast period. This is attributed to the ease of use, mobility, and the real-time result they provide. The demand for these variants is growing in remote and rural areas, where the infrastructure is often inadequate to support conventional trolley/-cart-based devices. The expanding trend of home-based care, especially since the pandemic and among the elderly, further drives this category.
The segment is categorized as below:
The hospitals, surgical centers, and diagnostics centers category dominated the market in 2024 with a share of 50%. This can be ascribed to the easy availability of sonography-based medical procedures at these medical centers, expansion in their number in key regions, and increase in the use of minimally invasive diagnostic and surgical techniques here.
Ambulatory care centers are the fastest-growing category, primarily due to the rising demand for affordable diagnostic services. Moreover, these places currently host fewer patients, which reduces waiting times and speeds up the procedures. The presence of fewer patients also lessens the chances of hospital-acquired infections, which took centerstage during the COVID-19 pandemic.
These end users are covered:
The color bifurcation dominates the market, and it will also witness the higher CAGR, of 10%, during the forecast period. Colored variants are a significant advancement over black-and-white ones, and they enable doctors to flip the mode to see the flow of blood. This enhances the precision of cardiac ultrasounds (echocardiograms) by offering better real-images of the blood vessels and chambers of the heart.
These device displays are covered:
The diagnostic category held the larger share in the market in 2024, of 80%, and it will also witness the higher CAGR during the forecast period. This is primarily because sonograms are widely performed to assess the functioning of the heart, check for cancer, and monitor the fetus in utero. The prevalence of chronic diseases, such as heart disease, cancer, stroke, respiratory disease and diabetes is increasing, due to the alteration in lifestyle and lack of access to preventive care. The incidence of various cancers and their mortality is increasing with age. The rapidly increasing burden of cancer is leading to increase in demand for oncology services, which further compels government organizations and healthcare providers to provide facilities for effective disease diagnosis and treatment. Cardiovascular disease is the disease of heart and blood vessels, which includes conditions, such as hypertension, coronary heart disease, heart failure, cerebrovascular disease and rheumatic heart disease. It is the leading cause of premature death around the world.
These product types are covered:
Drive strategic growth with comprehensive market analysis
Europe had the largest share of the sales revenue, of 40%, in 2024. The expansion in focused ultrasound's clinical applications and the early commercialization of these devices in the region, as well as the substantial healthcare expenditure across the developed European countries (such as Germany, France, the U.K., Italy, and Spain), are causing the ultrasound devices market in Europe to grow.
The ultrasound device market in Asia-Pacific is expected to grow at the highest rate, of 9%, due to improving healthcare infrastructure, increasing prevalence of chronic and lifestyle associated diseases, and strengthening of networks of international device manufacturers in Asia-Pacific. As per studies, over 1.4 million cases were diagnosed in India in 2022, while the incidence in China stood at 341.75 per 100,000. Further, as per the WHO, in India, genetic birth defects are seen in 61 to 69.9 in every 1,000 live births. These conditions also account for 7% of the deaths in the neonatal stage and 3.3 million deaths of children aged less than 5 each year.
The growing geriatric population is also driving the growth of the market. As per the WHO, 28% of the people in China will be 60 years old or older by 2040. Similarly, India, this population would grow to 347 million by 2050 from 153 million in 2023. Moreover, Japan and South Korea have the two oldest populations on earth, with 37.5% of the former’s and 39.4% of the latter’s population forecast to be at least 65 years old by mid-century.
In addition, the increasing healthcare cost is also driving the growth of the market.
These regions and countries have been analyzed:
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages